Benzonatate capsules, 100mg, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., I...

FDA Drug Recall #D-1124-2022 — Class I — January 15, 2021

Recall Summary

Recall Number D-1124-2022
Classification Class I — Serious risk
Date Initiated January 15, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Calvin Scott & Company, Inc.
Location Albuquerque, NM
Product Type Drugs
Quantity 10 bottles

Product Description

Benzonatate capsules, 100mg, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 67877-0573-05

Reason for Recall

Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.

Distribution Pattern

1 physician in Alpharetta, GA

Lot / Code Information

CSI Lot: CS-20180W-004, Exp 3/22

Other Recalls from Calvin Scott & Company, Inc.

Recall # Classification Product Date
D-1123-2022 Class III Benzphetamine tablets, 50mg, CIII, repackaged i... Jan 15, 2021
D-0010-2021 Class II Diethylpropion, 75 mg tablets, Rx only, Distrib... Sep 16, 2020
D-0009-2021 Class II Diethylpropion, 25 mg tablets, Rx only, Distrib... Sep 16, 2020
D-0011-2021 Class II Phentermine, 30 mg capsules, Rx only, Distribut... Sep 16, 2020
D-1520-2020 Class II Topiramate 25mg Tabs White/round tablets, 10-co... Jul 27, 2020

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.